nivolumab,cg0070
kissei,bms,cg oncology
['cg0070', 'nivo', 'nivolumab', 'bladder']
moffitt's shares early results from a phase ib/ii trial evaluating safety &amp; efficacy of neoadjuvant cg0070 and nivolumab for muscle-invasive bladder cancer in cisplatin-ineligible patients. check out poster #65 today at #asco22. view abstract: 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.